Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 7/2012

Open Access 01-10-2012 | Original

Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study

Authors: Thomas-Martin Wallasch, Peter Kropp

Published in: The Journal of Headache and Pain | Issue 7/2012

Login to get access

Abstract

This prospective study investigated the effectiveness of a three-tier modularized out- and inpatient multidisciplinary integrated headache care program. N = 204 patients with frequent headaches (63 migraine, 11 tension-type headache, 59 migraine + tension-type headache, 68 medication-overuse headache and 3 with other primary headaches) were enrolled. Outcome measures at baseline, 6- and 12-month follow-ups included headache frequency, Migraine Disability Assessment (MIDAS), Hospital Anxiety and Depression Scale (HADS), standardized headache diary and a medication survey. Mean reduction in headache frequency was 5.5 ± 8.5 days/month, p < 0.001 at 6 months’ follow-up and 6.9 ± 8.3 days/month, p < 0.001 after 1 year. MIDAS decreased from 53.0 ± 60.8 to 37.0 ± 52.4 points, p < 0.001 after 6 months and 34.4 ± 53.2 points, p < 0.001 at 1 year. 44.0 % patients demonstrated at baseline an increased HAD-score for anxiety and 16.7 % of patients revealed a HAD-score indicating a depression. At the end of treatment statistically significant changes could be observed for anxiety (p < 0.001) and depression (p < 0.006). The intake frequency of attack-aborting medication decreased from 10.3 ± 7.3 days/month at admission to 4.7 ± 4.1 days/month, p < 0.001 after 6 months and reached 3.8 ± 3.5 days/month, p < 0.001 after 1 year. At baseline 37.9 % of patients had experience with non-pharmacological treatments and 87.0 % at 12-month follow-up. In conclusion, an integrated headache care program was successfully established. Positive health-related outcomes could be obtained with a multidisciplinary out- and inpatient headache treatment program.
Literature
1.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The Global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210, 17381554, 10.1111/j.1468-2982.2007.01288.xCrossRefPubMed
2.
Lantéri-Minet M, Duru G, Mudge M, Cotrell S (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31:837–850, 21464078, 10.1177/0333102411398400CrossRefPubMed
3.
Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89, 14581114, 10.1016/S0304-3959(03)00293-8, 1:STN:280:DC%2BD3srgsVGjuw%3D%3DCrossRefPubMed
4.
Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31:1015–1022, 21628444, 10.1177/0333102411410082CrossRefPubMed
5.
Silberstein SD, Lipton RB, Saper JR (2008) Chronic daily headache, including transformed migraine, chronic tension-type headache, and medication overuse. In: Silberstein SD, Lipton RB, Dodick DW (eds) Wolff’s headache and other head pain, 8th edn. Oxford University Press, New York, pp 315–378
6.
Steiner TJ, Antonaci F, Jensen R, Lainez MJA, Lantéri-Minet M, Valade D (2011) Recommendations for headache service organisation and delivery in Europe. J Headache Pain 12:419–426, 21380555, 10.1007/s10194-011-0320-x, 1:STN:280:DC%2BC3MnovFSjuw%3D%3DPubMedCentralCrossRefPubMed
7.
Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine study II. Headache 41:638–645, 11554951, 10.1046/j.1526-4610.2001.041007638.x, 1:STN:280:DC%2BD3MrhtVKjsQ%3D%3DCrossRefPubMed
8.
Devine JW, Farley JF, Hadsall RS (2005) Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey. Headache 45:1171–1180, 16178947, 10.1111/j.1526-4610.2005.00240.xCrossRefPubMed
9.
Pascual J, Lainez MJ, Baos V, Garcia ML, Lopez-Gil A (2007) Predictive model for the Migraine-ACT questionnaire in primary care. Curr Med Res Opin 23:3033–3039, 17967220, 10.1185/030079907X242791CrossRefPubMed
10.
Clouse JC, Osterhaus JT (1994) Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 28:659–664, 8069007, 1:STN:280:DyaK2czkvVWltQ%3D%3DPubMed
11.
Saper JR, Lake AE, Madden SF, Kreeger C (1999) Comprehensive/tertiary care for headache: a 6-month outcome study. Headache 39:249–263, 15613222, 10.1046/j.1526-4610.1999.3904249.x, 1:STN:280:DC%2BD2cnjslCqsw%3D%3DCrossRefPubMed
12.
Lang E, Kastner S, Neundörfer B, Bickel A (2001) Können Therapieempfehlungen die Effektivität der ambulanten Versorgung von Patienten mit Kopfschmerzen verbessern? Schmerz 15:229–240, 11810361, 10.1007/s004820100053, 1:STN:280:DC%2BD38%2FotFejuw%3D%3DCrossRefPubMed
13.
Lemstra M, Stewart B, Olszynski WP (2002) Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache 42:845–854, 12390609, 10.1046/j.1526-4610.2002.02202.xCrossRefPubMed
14.
Harpole LH, Samsa GP, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB (2003) Headache management program improves outcome for chronic headache. Headache 43:715–724, 12890125, 10.1046/j.1526-4610.2003.03128.xCrossRefPubMed
15.
Maizels M, Saenz V, Wirjo J (2003) Impact of a group-based model of disease management for headache. Headache 43:621–627, 12786921, 10.1046/j.1526-4610.2003.03104.xCrossRefPubMed
16.
Magnusson JE, Riess CM, Becker WJ (2004) Effectiveness of a multidisciplinary treatment program for chronic daily headache. Can J Neurol Sci 31:72–79, 15038474CrossRefPubMed
17.
Zeeberg P, Olesen J, Jensen R (2005) Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 25:1159–1167, 16305604, 10.1111/j.1468-2982.2005.00980.x, 1:STN:280:DC%2BD2MnisFartg%3D%3DCrossRefPubMed
18.
Rothrock JF, Parada VA, Sims C, Key V, Walters NS, Zweifler RM (2006) The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache 46:726–731, 16643574, 10.1111/j.1526-4610.2006.00428.xCrossRefPubMed
19.
Mongingi F, Ciccone G, Rota E, Ferrero L, Ugolini A, Evangelista QA, Ceccarelli M, Galassi C (2008) Effectiveness of an educational and physical programme in reducing headache, neck and shoulder pain: a workplace controlled trial. Cephalalgia 28:541–552, 10.1111/j.1468-2982.2008.01551.xCrossRef
20.
Matchar DB, Harpole L, Samsa GP, Jurgelski A, Lipton RB, Silberstein SD, Young W, Kori S, Blumenfeld A (2008) The headache management trial: a randomized study of coordinated care. Headache 48:1294–1310, 18547268, 10.1111/j.1526-4610.2007.01148.xCrossRefPubMed
21.
Lake AE, Saper JR, Hamel RL (2009) Comprehensive inpatient treatment of refractory chronic daily headache. Headache 49:555–562, 19245391, 10.1111/j.1526-4610.2009.01364.xCrossRefPubMed
22.
Gunreben-Stempfe B, Griessinger N, Lang E, Muehlhans B, Sittl R, Ulrich K (2009) Effectiveness of an intensive multidisciplinary headache treatment program. Headache 49:990–1000, 10.1111/j.1526-4610.2009.01448.xCrossRef
23.
Jensen R, Zeeberg P, Dehlendorff C, Olesen J (2010) Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia 30:1214–1224, 20855367, 10.1177/0333102410361403CrossRefPubMed
24.
Gaul C, van Doorn C, Webering N, Dlugay M, Katsarava Z, Diener HC, Fritsche G (2011) Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 12:475–483, 21544647, 10.1007/s10194-011-0348-yPubMedCentralCrossRefPubMed
25.
Gaul C, Bromstrup J, Fritsche G, Diener HC, Katsarava Z (2011) Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen headache centre. BMC Neurol 11:124, 21985562, 10.1186/1471-2377-11-124PubMedCentralCrossRefPubMed
26.
Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache 46:76–87, 10.1111/j.1526-4610.2006.00559.xCrossRef
27.
Wang SJ, Fuh JL, Lu SR, Juang KD (2001) Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 89:285–292, 11166485, 10.1016/S0304-3959(00)00380-8, 1:STN:280:DC%2BD3M7psFCksw%3D%3DCrossRefPubMed
28.
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24:9–160, 10.1111/j.1468-2982.2003.00824.xCrossRef
29.
Evers S, May A, Fritsche G, Kropp P, Lampl C, Limmroth V, Malzacher V, Sandor P, Straube A, Diener H-C (2008) Akuttherapie und Prophylaxe der Migräne—Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft und der Deutschen Gesellschaft für Neurologie. Nervenheilkunde 27:933–949
30.
Straube A, May A, Kropp P, Katsarava Z, Haag G, Lampl C, Sándor PS, Diener H-C, Evers S (2007) Therapie primärer chronischer Kopfschmerzen: Chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und andere chronische tägliche Kopfschmerzen—Evidenzbasierte Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft in Zusammenarbeit mit der Österreichischen Kopfschmerzgesellschaft und der Schweizerischen Kopfwehgesellschaft. Nervenheilkunde 26:186–199
31.
Diener HC, Gaul C, Jensen R, Göbel H, Heinze A, Silberstein SD (2011) Integrated headache care. Cephalalgia 31:1039–1047, 21636624, 10.1177/0333102411409075CrossRefPubMed
32.
Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994, 10496257, 10.1212/WNL.53.5.988, 1:STN:280:DyaK1MvisVGktA%3D%3DCrossRefPubMed
33.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56:20–28, 10.1212/WNL.56.suppl_1.S20CrossRef
34.
Herrmann-Lingen C, Buss U, Snaith RP (2005) Hospital Anxiety and Depression Scale—Deutsche Version (HADS-D); (2.Aufl.)
35.
Wallasch TM, Bek J, Pabel R, Modahl M, Demir M, Straube A (2009) AC-STB - Eine sektorenübergreifende Software zur Dokumentation und Verlaufskontrolle von Kopfschmerzpatienten. Der Schmerz 2:145–153, 10.1007/s00482-008-0745-6CrossRef
36.
Margraf J, Schneider S, Ehlers A (2005) Diagnostisches Interview bei psychischen Störungen (DIPS) (3. Aufl.). Springer, Berlin
37.
Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233, 8628042, 10.1097/00005650-199603000-00003CrossRefPubMed
38.
Bullinger M, Kirchberger I (1998) Fragebogen zum Allgemeinen Gesundheitszustand SF12
39.
Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 3:98–109, 10.1111/j.1526-4610.2006.00561.xCrossRef
40.
41.
Kabbouche MA, Powers SW, Vockell AL, LeCates SL, Ellinor PL, Segers A, Manning P, Burdine D, Hershey AD (2005) Outcome of a Multidisciplinary Approach to Pediatric Migraine at 1, 2 and 5 years. Headache 45:1298–1303, 16324161, 10.1111/j.1526-4610.2005.00261.xCrossRefPubMed
42.
Hagen K, Stovner LJ (2011) A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years. Acta Neurol Scand Suppl 191:38–43, 21711255, 10.1111/j.1600-0404.2011.01542.xCrossRefPubMed
43.
Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, Nappi G (2010) Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 30(3):329–336, 19614697, 1:STN:280:DC%2BC3cfmt12rsw%3D%3DPubMed
44.
Ghiotto N, Sances G, Galli F, Tassorelli C, Guaschino E, Sandrini G, Nappi G (2009) Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia 29(2):233–243, 19025549, 10.1111/j.1468-2982.2008.01712.x, 1:STN:280:DC%2BD1M%2FntV2gsQ%3D%3DCrossRefPubMed
45.
Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29(2):221–232, 18823363, 10.1111/j.1468-2982.2008.01711.x, 1:STN:280:DC%2BD1M%2FntVGrug%3D%3DCrossRefPubMed
46.
Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25:12–15, 15606564, 10.1111/j.1468-2982.2004.00789.x, 1:STN:280:DC%2BD2cnjtFCrtA%3D%3DCrossRefPubMed
47.
Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401, 20298963, 10.1016/S1474-4422(10)70008-9CrossRefPubMed
48.
Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical feature of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57:1694–1698, 11706113, 10.1212/WNL.57.9.1694, 1:CAS:528:DC%2BD38Xnsl0%3DCrossRefPubMed
49.
Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190–196, 15613213, 10.1046/j.1526-4610.1999.3903190.x, 1:STN:280:DC%2BD2cnjslCrtg%3D%3DCrossRefPubMed
50.
Micieli G, Manzoni GC, Granella F et al (1988) Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M (eds) Drug-Induced Headache. Springer, Berlin, pp 20–28, 10.1007/978-3-642-73327-7_5CrossRef
51.
Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60(10):1682–1683, 12771266, 10.1212/01.WNL.0000063322.14078.90, 1:STN:280:DC%2BD3s3kvVajuw%3D%3DCrossRefPubMed
52.
Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC (2001) Drug-induced headache: long-term follow up of withrawal therapy and persistence of drug misuse. Eur Neurol 45:229–235, 11385260, 10.1159/000052134, 1:CAS:528:DC%2BD3MXks1Kqt7s%3DCrossRefPubMed
53.
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790, 15007133, 10.1212/01.WNL.0000113747.18760.D2, 1:STN:280:DC%2BD2c7hslektw%3D%3DCrossRefPubMed
Metadata
Title
Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study
Authors
Thomas-Martin Wallasch
Peter Kropp
Publication date
01-10-2012
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 7/2012
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-012-0469-y

Other articles of this Issue 7/2012

The Journal of Headache and Pain 7/2012 Go to the issue

Tutorial

Migraine headache: a review of the molecular genetics of a common disorder

Original

The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients

Review Article

Future possibilities in migraine genetics

Brief Report

Psychotic aura symptoms in familial hemiplegic migraine type 2 (ATP1A2)

Original

Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples

Original

The burden of headache disorders in India: methodology and questionnaire validation for a community-based survey in Karnataka State